Immunic, Inc.
IMUX· Nasdaq
Released Feb 22, 2024, before the open
10-K filed Feb 22, 2024, 53 days after period end · 0001280776-24-000004
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Net Income | -$21.57M | -$56.47M | -$21.19M | -$11.16M |
| EPS Diluted | — | — | -$0.81 |
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
| -$0.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.